CIPLA (91)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Updated list of 40 equity securities eligible as non-cash component of liquid assets with VAR-based haircuts and 25% deposit limits per … | |||||||||||||||
Updated list of 40 equity securities eligible as non-cash component of liquid assets with VAR-based haircuts and 25% deposit limits per security.
| |||||||||||||||
Updated list of equity shares approved as non-cash component of liquid assets for SLB segment with applicable haircuts and quantity limits. | |||||||||||||||
Updated list of equity shares approved as non-cash component of liquid assets for SLB segment with applicable haircuts and quantity limits.
| |||||||||||||||
BSE announces demat auction for settlement number 798 covering 100 scrips with various quantities for physical delivery settlement. | |||||||||||||||
BSE announces demat auction for settlement number 798 covering 100 scrips with various quantities for physical delivery settlement.
| |||||||||||||||
BSE announces demat auction settlement for 98 scrips with failed delivery obligations across various securities. | |||||||||||||||
BSE announces demat auction settlement for 98 scrips with failed delivery obligations across various securities.
| |||||||||||||||
BSE demat auction settlement listing securities and quantities to be auctioned for settlement number 798 dated January 16, 2026. | |||||||||||||||
BSE demat auction settlement listing securities and quantities to be auctioned for settlement number 798 dated January 16, 2026.
| |||||||||||||||
BSE demat auction settlement listing scrips and quantities for settlement number 798 dated January 16, 2026. | |||||||||||||||
BSE demat auction settlement listing scrips and quantities for settlement number 798 dated January 16, 2026.
| |||||||||||||||
BSE announces the list of 139+ companies eligible for trading in Group A segment, representing high liquidity and quality securities … | |||||||||||||||
BSE announces the list of 139+ companies eligible for trading in Group A segment, representing high liquidity and quality securities including major blue-chip stocks across various sectors.
| |||||||||||||||
NATCO Pharma provides clarification on ongoing litigation news, while Cipla addresses USFDA Form 483 inspectional observations at supply … | |||||||||||||||
NATCO Pharma provides clarification on ongoing litigation news, while Cipla addresses USFDA Form 483 inspectional observations at supply partner Pharmathen's Greece facility.
| |||||||||||||||
NATCO Pharma clarifies ongoing litigation with no current material impact, while Cipla addresses USFDA Form 483 observations at partner … | |||||||||||||||
NATCO Pharma clarifies ongoing litigation with no current material impact, while Cipla addresses USFDA Form 483 observations at partner facility Pharmathen manufacturing Lanreotide Injection.
| |||||||||||||||
BSE updates the list of securities eligible for trading in the Securities Lending and Borrowing (SLB) segment, including major stocks across … | |||||||||||||||
BSE updates the list of securities eligible for trading in the Securities Lending and Borrowing (SLB) segment, including major stocks across various sectors.
| |||||||||||||||